Drug Shortage Report for SANDOZ FINASTERIDE

Last updated on 2022-11-02 History
Report ID 89387
Drug Identification Number 02322579
Brand name SANDOZ FINASTERIDE
Common or Proper name FINASTERIDE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) FINASTERIDE
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code G04CB
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2019-05-28
Estimated end date
Actual end date 2021-06-18
Shortage status Resolved
Updated date 2022-11-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2022-11-02 French Compare
v21 2022-11-02 English Compare
v20 2020-06-08 French Compare
v19 2020-06-08 English Compare
v18 2020-06-01 French Compare
v17 2020-06-01 English Compare
v16 2020-05-25 French Compare
v15 2020-05-25 English Compare
v14 2020-05-11 French Compare
v13 2020-05-11 English Compare
v12 2020-04-27 French Compare
v11 2020-04-27 English Compare
v10 2020-04-21 French Compare
v9 2020-04-21 English Compare
v8 2020-02-11 French Compare
v7 2020-02-11 English Compare
v6 2020-01-22 French Compare
v5 2020-01-22 English Compare
v4 2019-10-15 French Compare
v3 2019-10-15 English Compare

Showing 1 to 20 of 22